Acknowledgement
This study received funding from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare (HI14C1324), Handok Inc., Seoul, Republic of Korea (HANDOK 2021-006), and from CELLTRION PHARM, Inc. Chungcheongbuk-do, Republic of Korea (NCR 2019-6).
References
- Denton CP, Khanna D. Systemic sclerosis. Lancet 2017;390:1685-1699. https://doi.org/10.1016/S0140-6736(17)30933-9
- Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11. https://doi.org/10.1002/art.37715
- Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222-227. https://doi.org/10.1136/ard.2006.054593
- Kant S, Shah AA, Hummers LK, Wigley FM, Geetha D. ANCA-associated vasculitis in scleroderma: a renal perspective . Clin Nephrol 2018;90:413-418. https://doi.org/10.5414/CN109445
- Wu R, Su J, Zou YR, Zhu J. ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review. Eur J Med Res 2021;26:30.
- Moxey J, Huq M, Proudman S, et al. Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Res Ther 2019;21:57.
- Radwan Y, Berini S, Ernste F, Makol A. Proteinase 3 (PR3)-antineutrophil cytoplasmic antibody (ANCA)-associated vasculitic neuropathy in diffuse cutaneous systemic sclerosis: a rare duo. BMJ Case Rep 2019;12:e232987.
- Ha JW, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea. Clin Exp Rheumatol 2021;39 Suppl 131:111-118. https://doi.org/10.55563/clinexprheumatol/nkcry1
- Suppiah R, Robson JC, Grayson PC, et al.; DCVAS INVESTIGATORS. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis 2022;81:321-326. https://doi.org/10.1136/annrheumdis-2021-221796
- Robson JC, Grayson PC, Ponte C, et al.; DCVAS Investigators. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis 2022;81:315-320. https://doi.org/10.1136/annrheumdis-2021-221795
- Grayson PC, Ponte C, Suppiah R, et al.; DCVAS Study Group. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis 2022;81:309-314. https://doi.org/10.1136/annrheumdis-2021-221794
- van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747-1755. https://doi.org/10.1136/annrheumdis-2013-204424
- Do H, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Cancer-associated vasculitides: a single-centre case series. Clin Rheumatol 2023;42:151-158. https://doi.org/10.1007/s10067-022-06363-0
- Phatak S, Aggarwal A, Agarwal V, Lawrence A, Misra R. Antineutrophil cytoplasmic antibody (ANCA) testing: audit from a clinical immunology laboratory. Int J Rheum Dis 2017;20:774-778. https://doi.org/10.1111/1756-185X.12926
- Lee WI, Subramaniam K, Hawkins CA, Randall KL. The significance of ANCA positivity in patients with inflammatory bowel disease. Pathology 2019;51:634-639. https://doi.org/10.1016/j.pathol.2019.07.002
- Wong AH, Wong WK, Looi LM, Ratnasingam J, Lim SK. Propylthiouracil-induced antineutrophil cytoplasmic antibodies-associated vasculitis with renal and lung involvement. Case Rep Nephrol Dial 2022;12:105-111. https://doi.org/10.1159/000525182
- Alawneh D, Edrees A. Hydralazine-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a case report and literature review. Cureus 2022;14:e24132.
- Bossuyt X, Cohen Tervaert JW, Arimura Y, et al. Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017;13:683-692. https://doi.org/10.1038/nrrheum.2017.140
- Choi CB, Park YB, Lee SW. Antineutrophil cytoplasmic antibody-associated vasculitis in Korea: a narrative review. Yonsei Med J 2019;60:10-21. https://doi.org/10.3349/ymj.2019.60.1.10
- Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primers 2020;6:71.
- Quemeneur T, Mouthon L, Cacoub P, et al. Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine (Baltimore) 2013;92:1-9. https://doi.org/10.1097/MD.0b013e31827781fd
- Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol 2015;37:489-500. https://doi.org/10.1007/s00281-015-0505-5
- Ha JW, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Incidence and patterns of interstitial lung disease and their clinical impact on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis: Korean single-centre observational study. J Immunol Res 2022;2022:2499404.
- Ha JW, Hong YJ, Cha HJ, et al. A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis. Sci Rep 2022;12:19253.